Naoki Takegawa

Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).

WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer.

Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer.

Journal: Molecular diagnosis & therapy
Published: August 01, 2025

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Journal: Cancers
Published: December 29, 2024

Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.

Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: October 01, 2024

Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group.

Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group.

Journal: Japanese journal of clinical oncology
Published: June 11, 2024

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.

Journal: Lancet (London, England)
Published: December 12, 2023

Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab.

Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab.

Journal: Diabetology international
Published: June 26, 2023

Strategic coastal dike shape for enhanced tsunami overflow reduction.

Strategic coastal dike shape for enhanced tsunami overflow reduction.

Journal: PloS one
Published: June 19, 2023

A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.

A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.

Journal: Targeted oncology
Published: March 24, 2023

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Journal: Oncology letters
Published: March 16, 2023

Traceability Management System Using Blockchain Technology and Cost Estimation in the Metrology Field.

Traceability Management System Using Blockchain Technology and Cost Estimation in the Metrology Field.

Journal: Sensors (Basel, Switzerland)
Published: January 12, 2023

The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer.

The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer.

Journal: PloS one
Published: November 14, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026